Clinical Trial Update: Efficacy and Safety Study of Oral Fludarabine Phosphate in Combination With Mitoxantrone as First Line Treatment in Follicular NHL [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of combining oral fludarabine phosphate with mitoxantrone as first-line therapy for follicular non-Hodgkin lymp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Fludarabine phosphate (Fludarabine phosphate)
• Mitoxantrone (mitoxantrone)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Non Hodgkin Lymphoma | Phase 2 | Status: COMPLETED